Avalo Therapeutics, Inc. (AVTX) Capital expenditures 2013–2022
Avalo Therapeutics, Inc. (AVTX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$95,000FY2022 · since FY2013: $29,268 → $95,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $95,000 | -15.9% |
| FY2021 | $113,000 | +79.4% |
| FY2020 | $63,000 | -76.0% |
| FY2019 | $262,013 | -53.6% |
| FY2018 | $564,415 | +2319.8% |
| FY2017 | $23,325 | -33.1% |
| FY2016 | $34,883 | +74.6% |
| FY2015 | $19,984 | +2.5% |
| FY2014 | $19,502 | -33.4% |
| FY2013 | $29,268 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice